↓ Skip to main content

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Overview of attention for article published in New England Journal of Medicine, September 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
183 news outlets
blogs
6 blogs
policy
1 policy source
twitter
696 X users
patent
3 patents
facebook
7 Facebook pages
video
1 YouTube creator

Citations

dimensions_citation
2536 Dimensions

Readers on

mendeley
1721 Mendeley